Zepbound 10 MG/0.5 ML pen 0.5ML
Ended Awarded
- Contract number
- SPE2DR26F72CZ
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $25,831
Award facts
- Contract value 100% obligated
- $25,830.91 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 12, 2025, for the supply of Zepbound 10 mg/0.5 mL pens with a ceiling value of $25,830.91. This is a firm fixed-price delivery order with no set-aside designation, and the ultimate completion date is November 13, 2025. The award will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. As a child contract under a larger vehicle, this delivery order draws from AmerisourceBergen's substantial Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued at $999,999,999.00 and extending through December 2026, which serves as a comprehensive pharmaceutical supply mechanism for federal military healthcare programs.
AmerisourceBergen Drug Corp is a major pharmaceutical distributor that serves as a critical vendor for federal medical procurement, particularly supporting Defense Health Agency, U.S. Coast Guard, and other military healthcare systems. The company's existing federal contract portfolio demonstrates expertise in delivering a broad range of pharmaceutical products across multiple therapeutic domains, including specialty medications, brand-name and generic drugs, and medical supplies. This award for Zepbound—a GLP-1 receptor agonist medication used for weight management—reflects the company's continued role as a primary supplier within the DLA's medical supply chain, supporting the agency's mission to provide necessary pharmaceutical products to military and federal healthcare beneficiaries.
Quick answers
Who was awarded contract SPE2DR26F72CZ?
SPE2DR26F72CZ was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 12, 2025.
How much is contract SPE2DR26F72CZ worth?
The government has obligated $25,831 on SPE2DR26F72CZ.
Is contract SPE2DR26F72CZ an order under another contract?
Yes. SPE2DR26F72CZ is a delivery order under SPE2DR25D1202, an indefinite delivery contract.
Was contract SPE2DR26F72CZ competed?
The extent of competition for SPE2DR26F72CZ was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award